Searched for
ASTRAZENECA STOCK TARGET
Walmart to join Nasdaq-100, replacing AstraZeneca from January 20Walmart will replace AstraZeneca in the Nasdaq-100 Index on January 20 following its move from the NYSE. The shift aligns with Walmart’s st...- AstraZeneca, Gilead vie for edge in race to treat tough breast cancerNew data from Europe's biggest oncology meeting reveals a high-stakes race for patients with a tough breast cancer. Astra and Daiichi's Dat...
- AstraZeneca targets 2024 growth but mixed views hit sharesIn almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker'...
- Technical Breakout Stocks: How AstraZeneca Pharma, Caplin Point and JB Chemicals are looking on charts for tomorrow’s tradeSectorally, buying was seen in realty, IT, metal, auto, and healthcare stocks, while selling pressure was seen in the banking space. Stocks...
- Breakout Stocks: How Ujjivan SFB, Godrej Industries and AstraZeneca Pharma are looking on charts for Monday’s tradeWe have collated a list of three stocks that either hit a fresh 52-week high, or all-time high or saw a volume or a price breakout.We spoke...
- Chart Check: AstraZeneca Pharma gives breakout from 7-month consolidation phase; where is the stock headed?Experts predict that AstraZeneca Pharma's stock price may hit 4000 levels in the next month after breaking out from a 7-month-long consolid...
- From game-changer to back-up: J&J's COVID vaccine struggles in EuropeThe Johnson & Johnson single-dose vaccine was considered to be a game changer when it rolled out. However, two months post it's arrival, it...
- Countries seek more Moderna, Pfizer/BioNTech shots as concerns mount over rival vaccinesCountries in Europe and Asia, as well as South Africa, are limiting or halting use of AstraZeneca's shot over safety concerns. Rollout of J...
- Australia shares slip after government scraps vaccination targetsThe S&P/ASX 200 index slipped 0.3 per cent to 6,974, closing lower for the second straight session. Last week, it had posted its best weekl...
- South Africa puts on hold AstraZeneca vaccination rollout after concern over efficacyIn a nationwide broadcast on Sunday evening, Health Minister Mkhize said that the roll-out will be put on hold until a committee of scienti...
- AstraZeneca to acquire Alexion in $39 billion dealAlexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.
- Moderna mania draws bitcoin comparisons while shorts bleedModerna jumped as much as 17% in New York Tuesday. The stock has surged about 73% and added more than $28 billion in market value over the ...
- SII to seek emergency use authorisation for AstraZeneca Covid vaccine in 2 weeks: PoonawallaAdar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting the data for the clinical trials to the DCG...
- AstraZeneca in first COVID-19 vaccine deal with Chinese companyThe deal underscores Astra's frontrunner position in a global race to deliver an effective vaccine, given that Chinese ventures are leading...
- Buy AstraZeneca Pharma, target price Rs 3,300: Jayesh BhanushaliThe analyst suggested a stoploss at Rs 2850 .
- Dr Reddy's climbs as drug maker launches Nexium's genericFollowing the development, the DRL stock surged 6.32 per cent to hit a high of Rs 4,222.75. The scrip was nearly 3 per cent away from its 5...
- AstraZeneca rallies over 37% in June on Forxiga launch; more gains likelyAstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...
- Pfizer boss enters lion's den of UK politics to sell AstraZeneca dealIn Tuesday's sessions lawmakers will also interrogate AstraZeneca's French CEO Pascal Soriot and business minister Vince Cable.
- AstraZeneca up 20% on delisting proposal, locked in upper circuit at Rs 1,110.90AstraZeneca said in the filing before markets opened on Monday that its board received a request from its promoter to initiate a voluntary ...
- AstraZeneca to close its Bangalore R&D unitThe decision to shut the R&D centre is part of an ongoing global restructuring exercise, said the company that employs over 1,200 people in...
Load More
